# Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026
Canonical URL: https://biopharmsignal.com/news/PAVM/lucid-diagnostics-to-hold-first-quarter-2026-business-update-conference-call-and-webcast-on-may-14-2026
Ticker: PAVM
Company: PAVmed
Source: PAVmed
Published: 2026-04-30 12:31 EST
Original Source URL: https://ir.pavmed.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-15 12:00 EST — [PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/PAVM/pavmed-provides-business-update-and-reports-first-quarter-2026-financial-results) — Source: PAVmed
- 2026-05-14 12:00 EST — [Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/PAVM/lucid-diagnostics-provides-business-update-and-reports-first-quarter-2026-financ-e9046b9f) — Source: PAVmed
- 2026-05-01 12:31 EST — [PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026](https://biopharmsignal.com/news/PAVM/pavmed-to-hold-first-quarter-2026-business-update-conference-call-and-webcast-on-may-15-2026) — Source: PAVmed
- 2026-04-30 12:31 EST — [Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026](https://biopharmsignal.com/news/PAVM/lucid-diagnostics-to-hold-first-quarter-2026-business-update-conference-call-and-webcast-on-may-14-2026) — Source: PAVmed
- 2026-04-24 14:23 EST — [Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock](https://biopharmsignal.com/news/PAVM/lucid-diagnostics-announces-closing-of-18-million-underwritten-offering-of-commo-146a4cff) — Source: PAVmed
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)